Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Transfusion-associated hyperkalemia in pediatric population: Prevalence, risk factors, survival, infusion rate, and RBC unit features.

Tytuł:
Transfusion-associated hyperkalemia in pediatric population: Prevalence, risk factors, survival, infusion rate, and RBC unit features.
Autorzy:
Yamada C; Department of Pathology, Division of Transfusion Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Edelson M; Department of Pathology and Laboratory Medicine, Nemours/A.I. DuPont Hospital for Children, Wilmington, Delaware, USA.
Lee A; Division of Anesthesiology, Pain and Perioperative Medicine, Children's National Hospital, George Washington School of Medicine & Health Sciences, Washington, District of Columbia, USA.
Saifee NH; Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, Seattle Children's and University of Washington, Seattle, Washington, USA.
Bahar B; Division of Pathology & Laboratory Medicine, Children's National Hospital, George Washington School of Medicine & Health Sciences, Washington, District of Columbia, USA.
Delaney M; Division of Pathology & Laboratory Medicine, Children's National Hospital, George Washington School of Medicine & Health Sciences, Washington, District of Columbia, USA.
Źródło:
Transfusion [Transfusion] 2021 Apr; Vol. 61 (4), pp. 1093-1101. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Journal Article; Multicenter Study
Język:
English
Imprint Name(s):
Original Publication: Arlington, Va. : American Association Of Blood Banks
MeSH Terms:
Erythrocyte Transfusion*/adverse effects
Hyperkalemia*/diagnosis
Hyperkalemia*/epidemiology
Hyperkalemia*/etiology
Hyperkalemia*/mortality
Infusions, Intravenous*/adverse effects
Infusions, Intravenous*/statistics & numerical data
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Case-Control Studies ; Comorbidity ; Mortality/trends ; Potassium/blood ; Prevalence ; Retrospective Studies ; Risk Factors ; Transfusion Medicine/statistics & numerical data
References:
Vraets A, Lin Y, Callum JL. Transfusion-associated hyperkalemia. Transfus Med Rev. 2011;25:184-96.
Brown KA, Bissonnette B, McIntyre B. Hyperkalaemia during rapid blood transfusion and hypovolaemic cardiac arrest in children. Can J Anaesth. 1990;37:747-54.
Lockwood WB, Leonard J, Liles SL. Storage, monitoring, pretransfusion processing, and distribution of blood components. In: Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda, MD: AABB; 2008. p. 289.
Moroff G, Holme S, AuBuchon JP, Heaton WA, Sweeney JD, Friedman LI. Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion. 1999;39:128-34.
Strauss RG. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion. 2000;40:1528-40.
Liu EA, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr. 1994;125:92-6.
Lee DA, Slagle TA, Jackson TM, Evans CS. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells. J Pediatr. 1995;126:280-6.
Strauss RG, Burmeister LF, Johnson K, James T, Miller J, Cordle DG, et al. AS-1 red cells for neonatal transfusions: A randomized trial assessing donor exposure and safety. Transfusion. 1996;36:873-8.
Hall TL, Barnes A, Miller JR, Bethencourt DM, Nestor L. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion. 1993;33:606-9.
Chen CH, Hong CL, Kau YC, Lee HL, Chen CK, Shyr MH. Fatal hyperkalemia during rapid and massive blood transfusion in a child undergoing hip surgery-A case report. Acta Anaesthesiol Sin. 1999;37:163-6.
Buntain SG, Pabari M. Massive transfusion and hyperkalaemic cardiac arrest in craniofacial surgery in a child. Anaesth Intensive Care. 1999;27:530-3.
Baz EM, Kanazi GE, Mahfouz RA, Obeid MY. An unusual case of hyperkalaemia-induced cardiac arrest in a paediatric patient during transfusion of a 'fresh' 6-day-old blood unit. Transfus Med. 2002;12:383-6.
Woodforth IJ. Resuscitation from transfusion-associated hyperkalaemic ventricular fibrillation. Anaesth Intensive Care. 2007;35:110-3.
Smith HM, Farrow SJ, Ackerman JD, Stubbs JR, Sprung J. Cardiac arrests associated with hyperkalemia during red blood cell transfusion: A case series. Anesth Analg. 2008;106:1062-9, table of contents.
Stoops CM. Acute hyperkalemia associated with massive blood replacement. Anesth Analg. 1983;62:1044.
Carvalho B, Quiney NF. 'Near-miss' hyperkalaemic cardiac arrest associated with rapid blood transfusion. Anaesthesia. 1999;54:1094-6.
Tsukamoto S, Maruyama K, Nakagawa H, Iwase Y, Kitamura A, Hayashida M. Fatal hyperkalemia due to rapid red cell transfusion in a critically ill patient. J Nippon Med Sch. 2009;76:258-64.
Rizos CV, Milionis HJ, Elisaf MS. Severe hyperkalemia following blood transfusions: Is there a link? World J Nephrol. 2017;6:53-6.
Strauss RG. RBC storage and avoiding hyperkalemia from transfusions to neonates & infants. Transfusion. 2010;50:1862-5.
Fung MK, Roseff SD, Vermoch KL. Blood component preferences of transfusion services supporting infant transfusions: A University HealthSystem Consortium benchmarking study. Transfusion. 2010;50:1921-5.
Bhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL, Domino KB, Haberkern CM, et al. Anesthesia-related cardiac arrest in children: Update from the pediatric perioperative cardiac arrest registry. Anesth Analg. 2007;105:344-50.
Brown KA, Bissonnette B, MacDonald M, Poon AO. Hyperkalaemia during massive blood transfusion in paediatric craniofacial surgery. Can J Anaesth. 1990;37:401-8.
Vohra HA, Adluri K, Willets R, Horsburgh A, Barron DJ, Brawn WJ. Changes in potassium concentration and haematocrit associated with cardiopulmonary bypass in paediatric cardiac surgery. Perfusion. 2007;22:87-92.
Carmichael D, Hosty T, Kastl D, Beckman D. Hypokalemia and massive transfusion. South Med J. 1984;77:315-7.
Contributed Indexing:
Keywords: RBC transfusion; non infectious; transfusion complications; transfusion practices (neonatal, pediatrics)
Substance Nomenclature:
RWP5GA015D (Potassium)
Entry Date(s):
Date Created: 20210210 Date Completed: 20210701 Latest Revision: 20240319
Update Code:
20240320
DOI:
10.1111/trf.16300
PMID:
33565635
Czasopismo naukowe
Background: Hyperkalemia is a rare life-threatening complication of red blood cell (RBC) transfusion. Stored RBCs leak intracellular potassium (K+) into the supernatant; irradiation potentiates the K+ leak. As the characteristics of patients and implicated RBCs have not been studied systematically, a multicenter study of transfusion-associated hyperkalemia (TAH) in the pediatric population was conducted through the AABB Pediatric Transfusion Medicine Subsection.
Study Design: The medical records of patients <18 years old were retrospectively queried for hyperkalemia occurrence during or ≤12 h after the completion of RBC transfusion in a 1-year period. Collected data included patient demographics, diagnosis, medical history, timing of hyperkalemia and transfusion, mortality, and RBC unit characteristics.
Results/findings: A total of 3777 patients received 19,649 RBC units during the study period in four facilities. TAH was found in 35 patients (0.93%) in 37 occurrences. The patient median age and weight were 1.28 years and 9.80 kg, respectively. All patients had multiple serious comorbidities. There were 79 RBC units transfused in the TAH events; 62% were irradiated, and the median age of the units was 10 days. The median total RBC volume transfused ≤12 h before TAH was 24% of patient estimated total blood volume, and the median infusion rate (IR) was19.6 ml/kg/h. Mortality rate within 1 day after the TAH event was 20%.
Conclusions: The prevalence of TAH in children was low; however, the 1-day mortality rate was 20%. Patients with multiple comorbidities may be at higher risk for TAH. The IR was higher for patients who had TAH than the IR threshold for safe transfusion.
(© 2021 AABB.)
Comment in: Transfusion. 2021 Apr;61(4):996-999. (PMID: 33831227)
Comment in: Transfusion. 2022 Jan;62(1):252-253. (PMID: 35023158)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies